Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05718245 · ClinicalTrials.gov registry record · NA
HEPA, PM2.5, and Cardiometabolic Health
A NA study of Air Pollution and Cardiometabolic Health, sponsored by University of Southern California.
- Recruiting
- Registry status
- NA
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT05718245 is a NA study of Air Pollution and Cardiometabolic Health that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 52 participants, roughly in line with the 55-participant average among 7 other Air Pollution trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT05718245, a NA study of Air Pollution and Cardiometabolic Health, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this randomized, double-blind, crossover trial is to test the hypothesis that a longer-term indoor HEPA filtration intervention can improve cardiometabolic profiles by reducing indoor PM2.5 exposures in at-risk individuals.
Conditions Studied
Interventions
- DEVICE HEPA filter
- DEVICE Sham filter
Study Locations (1)
California
- Keck School of Medicine, University of Southern California - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05718245
The ClinicalTrials.gov registry entry for NCT05718245 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 55-participant average among 7 other Air Pollution trials with a reported enrollment target. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Air Pollution appearing as the primary indexed condition, and to 2 interventions - of which HEPA filter is the first listed.
NCT05718245 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05718245 about?
NCT05718245 is a clinical study titled "HEPA, PM2.5, and Cardiometabolic Health". The goal of this randomized, double-blind, crossover trial is to test the hypothesis that a longer-term indoor HEPA filtration intervention can improve cardiometabolic profiles by reducing indoor PM2.5 exposures in at-risk individuals.
What is the current status of trial NCT05718245?
This trial is currently recruiting. It is a NA study. The enrollment target is 52 participants. The study started on 2023-03-15. Estimated completion is 2026-12-31.
What conditions does trial NCT05718245 study?
This clinical trial studies the following conditions: Air Pollution, Cardiometabolic Health.
What interventions are being tested in trial NCT05718245?
The interventions under investigation include: HEPA filter (DEVICE), Sham filter (DEVICE).
Who is sponsoring clinical trial NCT05718245?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05718245 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Air Pollution
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Role of Macrophage Activation in Lung Injury Following Ozone Exposure
RECRUITING · NA
-
Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
RECRUITING · NA
-
Does Sildenafil Increase Exercise Performance in Air Pollution?
COMPLETED · NA
-
Particulate Matter, Blood Pressure, and the Sympathetic Nervous System
COMPLETED · NA
-
Boston Puerto Rican Health Study
COMPLETED · NA
-
Air Pollution: Strategies for Personalized Intervention to Reduce Exposure
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.